The present invention is directed to compounds of Formula (I),
and to pharmaceutically acceptable salts thereof, their synthesis, and their use as Raf inhibitors.
本发明涉及式(I)化合物及其药学上可接受的盐,其合成以及作为Raf抑制剂的用途。
Pyrazole compounds as RAF inhibitors
申请人:Pfizer Inc.
公开号:US07772246B2
公开(公告)日:2010-08-10
The present invention is directed to compounds of Formula (I),
and to pharmaceutically acceptable salts thereof, their synthesis, and their use as Raf inhibitors.
本发明涉及式(I)化合物,以及其药学上可接受的盐、它们的合成和它们作为Raf抑制剂的用途。
[EN] PYRAZOLE COMPOUNDS AND THEIR USE AS RAF INHIBITORS<br/>[FR] COMPOSÉS PYRAZOLES